BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 17513738)

  • 1. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
    Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
    J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 is required for the induction of high dose oral tolerance.
    Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
    Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
    Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
    J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CD80 and CD86 on T cell cytokine production.
    Petro TM; Chen SS; Panther RB
    Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
    Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
    J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.
    Walker LS; Wiggett HE; Gaspal FM; Raykundalia CR; Goodall MD; Toellner KM; Lane PJ
    J Immunol; 2003 Jan; 170(1):91-8. PubMed ID: 12496387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness.
    Tsuyuki S; Tsuyuki J; Einsle K; Kopf M; Coyle AJ
    J Exp Med; 1997 May; 185(9):1671-9. PubMed ID: 9151904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.